Pierce Capital Research

Pierce Capital Research

Home
Archive
Leaderboard
About

June 2025

Tesla’s Robotaxi Milestone & Biotech’s Big Opportunity
Taking a Look at Tesla (TSLA) & Biotech (XBI).
 • 
Steve Wagner
Connecting the Dots: AST SpaceMobile’s Global Momentum Just Accelerated
Taking a Look at AST SpaceMobile's (ASTS) Progress.
 • 
Steve Wagner
Lockheed’s F-35 Under Fire: Budget Cuts & Ballooning Costs
Taking a Look at Lockheed Martin's (LMT) F-35 Program.
 • 
Steve Wagner
Discounted Assets, Premium Potential: The Case for Coherus Oncology
Taking a Look at Coherus Oncology (CHRS), Special Situation Arbitrage Idea.
 • 
Steve Wagner
Tesla’s Robotaxi Reality & dLocal’s $150M Leap
Taking a Look at Tesla (TSLA) vs. Uber/Waymo & dLocal's (DLO) Acquisition.
 • 
Steve Wagner
Clinical Gains & Digital Brains: Relay’s Clinical Progress & Verses’ AI Blueprint
Taking a Look at Relay Therapeutics (RLAY) & Verses AI (VRSSD) News.
 • 
Steve Wagner
Get Ahead of Market Trends: Exclusive Access to Premium Research
Premium Research Reports, Intrinsic Value Models for Companies in Our Coverage Ecosystem, & Portfolio Dashboard.
 • 
Steve Wagner

May 2025

Rocket Lab Making Moves, AST Securing Partnerships, Coherus Collabs with STORM, & Nvidia's Solid Quarter
We Took a Look at Rocket Lab (RKLB), AST SpaceMobile (ASTS), Coherus BioSciences (CHRS), & Nvidia (NVDA) this week.
 • 
Steve Wagner
New Platform. New Tools. Same Mission.
Transition to PCR, Premium Services, & Discount to Our Subscriber Base.
 • 
Steve Wagner
Boston Omaha Q1 2025 Earnings: Steady Growth, Narrowing Losses
Taking a Look at Boston Omaha's (BOC) Earnings Results.
 • 
Steve Wagner
dLocal Q1 2025: Record Growth,Rising Profits
Taking a Look at dLocal's (DLO) Earnings Results.
 • 
Steve Wagner
© 2025 Pierce Capital Research
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture